Journal of Bioequivalence Studies

Show Articles
Journal Properties
  • Number of Articles
    11
  • e-ISSN
    2575-551X
  • Publisher
    Annex Publishers, LLC
  • Indian UGC
  • DOAJ (latest)
Description
Journal of Bioequivalence Studies is a peer-reviewed, open-access publication focused on the critical evaluation of generic pharmaceuticals and biosimilars. It provides a platform for researchers, pharmaceutical scientists, and regulatory experts to share findings on bioequivalence testing, pharmacokinetic studies, and the development of safe and effective therapeutic alternatives. Key areas of interest include studies comparing the bioavailability and bioequivalence of generic drugs to their reference listed drugs (RLDs), as well as research on the development and approval of biosimilars. The journal covers various aspects of drug formulation, analytical methods, and statistical analysis essential for ensuring pharmaceutical quality and efficacy. It also addresses regulatory guidelines and international standards related to bioequivalence assessment, aiding both researchers and regulatory agencies. Indexed in several databases, the journal is an invaluable resource for the pharmaceutical industry and academia. Original research, reviews, and short communications are welcomed. The journal promotes the advancement of accessible and affordable healthcare while upholding rigorous scientific standards.